Money Manager’s Portfolio Shift Puts Palantir Alongside Healthcare Holdings

A portfolio manager’s recent disclosure of buying UnitedHealth Group and Palantir Technologies while trimming animal-health company Zoetis has drawn attention to how institutional investors are positioning across the software and healthcare sectors, according to a report in The Globe and Mail.

The inclusion of Palantir Technologies Inc. (PLTR) in the manager’s purchases highlights continued institutional interest in the data-analytics company. Palantir, classified in the software-infrastructure industry, builds software platforms used by the intelligence community in the United States, the United Kingdom, and internationally, including work supporting counterterrorism investigations.

Palantir shares traded at $170.50 on the day of the report, down 0.07% from the prior close of $170.62, giving the company a market capitalization of roughly $439.7 billion. The stock’s large-cap status places it among the most valuable technology names, a notable milestone for a company that has historically drawn much of its revenue from government contracts alongside a growing commercial customer base.

The manager’s addition of UnitedHealth — a managed-care and health-services heavyweight — alongside Palantir suggests a barbell approach pairing defensive healthcare exposure with a technology firm whose products sit at the intersection of big data and government services. The decision to exit Zoetis, an animal-health pharmaceutical company, was not detailed in the report, and the manager’s specific rationale for the moves was not fully disclosed.

Portfolio moves by prominent money managers often draw scrutiny because quarterly disclosures offer a public window into institutional positioning. For defence-adjacent technology companies like Palantir, buy-side endorsements from generalist managers are frequently read as a signal of broadening investor appeal beyond the sector’s traditional specialist base.

For Palantir specifically, institutional accumulation comes as the company has diversified its revenue mix between government and commercial customers. Its Gotham platform, which integrates with other software environments, remains central to its public-sector work, while its Foundry and Artificial Intelligence Platform (AIP) offerings have driven growth in commercial markets.

No transaction sizes or position weights were disclosed in the report, so the significance of the purchase within the manager’s overall portfolio is unclear. Journalists and investors typically look to subsequent filings, such as 13F quarterly reports, for full position details.

What to watch

• Palantir’s next quarterly earnings report, including government versus commercial revenue breakdowns
• Upcoming 13F filings that may confirm the size of the manager’s new Palantir position
• Any new public-sector contract announcements that could affect revenue visibility

Source: original release